homehome Home chatchat Notifications


A more sustainable leather industry built from a petri dish

This biomaterial is not only better, but more humane than traditional leather.

Alexandru Micu
July 11, 2016 @ 6:58 pm

share Share

Modern Meadow, a Brooklyn startup founded in 2011, might be able to achieve the impossible: make leather goods that even PETA approves of. The company has secured US$53.5 million in funding for their plan of growing leather in labs, not from livestock.

Image credits Tomas Castelazo

Cows the world over, rejoice! This animal-free method for leather production could mean an end to the slaughter of countless beasts, and that’s not all. The method removes the need for the highly-pollutant processes needed to clean, cure and tan leather obtained from traditional sources. Biofabricating the material allows Modern Meadow to “design, grew, and assemble collagen” and proteins into a type of leather that has all the pros and none of the cons of animal leather. The material is biologically identical to the traditional one, sans the elements that require toxic processing to get rid of.

“We’re making a material that has no hair flesh or fat on it. So the liming and toxicity you see elsewhere in the leather trade is eliminated,” said Andras Forgacs, COE and co-founder of Modern Meadow.

Because the whole process takes place in the lab under precise control the company can supply designers with leather of specific characteristics, so they aren’t limited to naturally available materials any longer. Forgacs believes that along with their cruelty-free model, this flexibility will help the company become the world’s go-to source of leather.

The company is also producing meat in its labs (which might actually be better for you than the real thing,) and Forgacs is a firm believer that this is a much more civilized source than the slaughtering of animals.

Modern Meadow now plans to move from the research and development phase of the project into preparation for full-scale production. Their first goals are to set up a studio in New York and gearing their first factory for production.

The company now intends to move forward from the research and development phase of the project and expand in preparation for full-scale production. In the immediate future, this means setting up a studio in New York and readying its first factory.

Horizons Ventures’ Bart Swanson, whose firm is one of the investors of Modern Meadow, believes that the company will secure its market share despite the higher cost of production compared to farms.

“It took us a long time to rid ourselves of total dependence on oil and carbon fuels, now renewable energy, LED lighting and electric vehicles have traction,” he said.

share Share

Westerners cheat AI agents while Japanese treat them with respect

Japan’s robots are redefining work, care, and education — with lessons for the world.

Scientists Turn to Smelly Frogs to Fight Superbugs: How Their Slime Might Be the Key to Our Next Antibiotics

Researchers engineer synthetic antibiotics from frog slime that kill deadly bacteria without harming humans.

This Popular Zero-Calorie Sugar Substitute May Be Making You Hungrier, Not Slimmer

Zero-calorie sweeteners might confuse the brain, especially in people with obesity

Any Kind of Exercise, At Any Age, Boosts Your Brain

Even light physical activity can sharpen memory and boost mood across all ages.

A Brain Implant Just Turned a Woman’s Thoughts Into Speech in Near Real Time

This tech restores speech in real time for people who can’t talk, using only brain signals.

Using screens in bed increases insomnia risk by 59% — but social media isn’t the worst offender

Forget blue light, the real reason screens disrupt sleep may be simpler than experts thought.

Beetles Conquered Earth by Evolving a Tiny Chemical Factory

There are around 66,000 species of rove beetles and one researcher proposes it's because of one special gland.

We Should Start Worrying About Space Piracy. Here's Why This Could be A Big Deal

“We are arguing that it’s already started," say experts.

An Experimental Drug Just Slashed Genetic Heart Risk by 94%

One in 10 people carry this genetic heart risk. There's never been a treatment — until now.

We’re Getting Very Close to a Birth Control Pill for Men

Scientists may have just cracked the code for male birth control.